Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
08/1997
08/21/1997WO1997030072A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii
08/21/1997WO1997030024A2 Lipids and their use, for example, in liposomes
08/21/1997WO1997029765A1 Antimicrobial peptides and methods of use
08/21/1997WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
08/21/1997CA2595040A1 Isolation and use of nch-sh3 binding peptides
08/21/1997CA2412954A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii
08/21/1997CA2246811A1 Macrocyclic peptides useful in the treatment of thrombin related disorders
08/21/1997CA2242660A1 Antimicrobial peptides and methods of use
08/20/1997EP0789783A1 Antigen binding peptides (abtides) from peptide libraries
08/20/1997EP0789710A1 Peptides for anti-allergy treatment
08/20/1997EP0789709A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
08/20/1997EP0789708A1 Multifunctional molecular complexes for gene transfer to cells
08/20/1997EP0789591A1 Methods for identifying individuals suffering from a cellular abnormality
08/20/1997EP0789579A1 Aza cyclohexapeptide compounds
08/20/1997EP0789577A1 Synthesis of n-substituted oligomers
08/20/1997CN1157655A Method of determination of specific immunoglobulin using multiple antigens
08/20/1997CN1157621A Proinsulin peptide compound for detecting and treating type I diabetes
08/20/1997CN1157413A Synthetic peptide reagent for detecting coxsackie virus anti-body
08/19/1997US5659041 Medical diagnosis, therapy
08/19/1997US5659018 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
08/19/1997US5658885 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
08/19/1997US5658872 Biodegradable complexing agent
08/19/1997US5658754 Cell-free synthesis and isolation of novel genes and polypeptides
08/19/1997US5658555 Photoprotective/cosmetic compositions comprising synergistic admixture of sunscreen compounds/nanopigments
08/19/1997CA1339339C Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
08/14/1997WO1997029372A1 Affinity labeling libraries and applications thereof
08/14/1997WO1997029199A2 Prostate specific antigen peptides and uses thereof
08/14/1997WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
08/14/1997WO1997028818A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
08/14/1997DE19605175A1 Lipidverbindungen und deren Verwendung Lipid compounds and their use
08/14/1997CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
08/14/1997CA2244941A1 Prostate specifice antibodies and uses thereof
08/14/1997CA2244911A1 Synthesis of vip analog
08/14/1997CA2244110A1 Novel methods of vaccination and vaccines thereof comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
08/13/1997EP0789030A1 Fibrinogen binding peptides
08/13/1997EP0788512A1 Proinsulin peptide compounds for detecting and treating type i diabetes
08/13/1997EP0788511A1 Cyclic hexapeptides having antibiotic activity
08/13/1997EP0788509A1 Therapeutic peptide derivatives
08/13/1997EP0788370A1 Cyclic semi-random peptide libraries
08/13/1997CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels
08/13/1997CN1156964A Novel Peptides
08/12/1997US5656727 Water solubility
08/12/1997US5656726 Antiinflammatory agents, antiarthritic agents
08/12/1997US5656721 Having sugar moiety; prolonged duration of action
08/12/1997US5656602 Linear or cyclic peptides of at least five residues
08/12/1997US5656600 Modified polypeptides
08/12/1997US5656596 Using a polypeptide
08/12/1997US5656459 Process for the preparation of cyclosporin a from tolypocladium species
08/12/1997US5656456 Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof
08/12/1997US5656439 Peptide having 3-hydroxypyridinium crosslink
08/12/1997US5655652 Center dispense suture package
08/12/1997CA1339260C Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
08/07/1997WO1997027864A1 Cyclic peptide antifungal agents
08/07/1997WO1997021815A3 Antifungal proteins
08/07/1997WO1997019106A3 Collagen-like peptoid residue-containing structures
08/07/1997CA2244730A1 Anti-inflammatory peptides derived from c-reactive protein
08/07/1997CA2244238A1 Cyclic peptide antifungal agents
08/06/1997EP0787299A1 Receptor for a bacillus thuringiensis toxin
08/06/1997EP0787191A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
08/06/1997EP0787187A1 Her4 human receptor tyrosine kinase
08/06/1997EP0787147A1 Compositions and treatment for multiple sclerosis
08/06/1997EP0787143A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
08/06/1997EP0787140A1 Process for performing retro-aldol reaction
08/06/1997EP0787139A1 Synthetic peptides and vaccines comprising same
08/06/1997EP0787016A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
08/06/1997EP0787010A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes
08/06/1997EP0787009A1 Cancer inhibitory peptides
08/06/1997EP0585397B1 Bombesin analogs
08/05/1997US5654399 Tetrapeptide derivative having antitumor activity
08/05/1997US5654277 Inhibiting tumor metastasis in mammals by administering specific tetra- or pentapeptides
08/05/1997US5654276 Peptides and compounds that bind to the IL-5 receptor
08/05/1997US5654274 Inhibit growth of target cells, viruses or virally-infected cells
08/05/1997US5654272 Including an amino acid sequence of cysteine-(amino acid)-cysteine to complex the isotope and a target binding sequencefor target sites including atherosclerotic plaque and alzheimer's amyloid plaque; scintigraphy
08/05/1997US5654271 Fungicidally active compounds
08/05/1997US5654267 Wound healing agent
08/05/1997US5654151 High affinity HIV Nucleocapsid nucleic acid ligands
08/05/1997US5654145 Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
08/05/1997CA1339240C Synthetic vaccine against aids virus
08/05/1997CA1339210C Recombinant techniques for production of novel natriuretic and vasodilator peptides
08/05/1997CA1339205C Oligonucleotide-polyamide conjugates
08/02/1997CA2196368A1 Fibrinogen binding peptides
07/1997
07/31/1997WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20
07/31/1997WO1997027298A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
07/31/1997WO1997027276A2 Nucleic acids encoding polypeptides having absidia lipase activity
07/31/1997WO1997027220A2 Substrates and inhibitors for cysteine protease ich-1
07/31/1997WO1997026784A1 Induction of immune response against desired determinants
07/31/1997WO1997022360A3 Control of protein synthesis, and screening method for agents
07/31/1997CA2244412A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor
07/31/1997CA2243497A1 Substrates and inhibitors for cysteine protease ich-1
07/31/1997CA2242200A1 Toxoplasma gondii antigen tg20
07/30/1997EP0785945A1 New peptides with immunomodulatory effects
07/30/1997EP0785713A1 Creating an aerosolized formulation of insulin
07/30/1997EP0636146B1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
07/29/1997US5652342 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
07/29/1997US5652335 Adamantyl amide or ester derivative; improves blood-brain barrier permeability
07/29/1997US5652219 Hemoregulatory peptides
07/29/1997US5652213 Cyclic peptide antifungal agents
07/29/1997US5652211 Treatment of septic shock
07/29/1997US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes
07/29/1997US5652097 In vitro test to evaluate the inhibition potency of angiotensin II antagonists on angiotensinogen